Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.2850
+0.0050 (1.79%)
Mar 18, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 223.36 million as of March 18, 2026. Its market cap has increased by 1,047.69% in one year.
Market Cap
223.36M
Enterprise Value
228.57M
Revenue
18.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has increased from 196.70M to 223.36M, an increase of 13.55%. That is a compound annual growth rate of 2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 223.36M | -0.44% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | 196.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 826.47M |
| PolyNovo | 659.76M |
| Aroa Biosurgery | 208.15M |
| EMVision Medical Devices | 148.70M |
| SomnoMed | 138.71M |
| Epiminder | 134.14M |
| Cleo Diagnostics | 64.33M |
| Compumedics | 60.93M |